##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 136 Download : 137

##plugins.themes.academic_pro.article.main##

Abstract

Supraventricular tachycardias are paroxysmal tachyarrhythmias which require atrial or atrioventricular nodal tissue or both for their initiation and maintenance & they are often recurrent, occasionally persistent, and a frequent cause of visits to emergency rooms and primary care physicians.

Keywords

uneventful physicians recurrent frequent

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Masaud Kakahmad Muhammad, Dr. Ahmed Shnyain Ali, & Dr. Mohammed Hashim Hussein Almyahi. (2023). Electrophysiology study in patients with supraventricular tachycardia. Texas Journal of Medical Science, 17, 77–84. https://doi.org/10.62480/tjms.2023.vol17.pp77-84
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Tikkanen I, Metsarinne K, Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia. Lancet 1985; 2:40-1.
  2. -Link MS. Introduction to the arrhythmias: a primer. EP Lab Digest 2007; 5:38-9.
  3. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104:1534-9.
  4. Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation 2010; 122:831-40.
  5. Mark S. Link, M.D. Evaluation and Initial Treatment of Supraventricular Tachycardia. NEJM 2012; 367:1438-48. DOI: 10.1056/NEJMcp1111259
  6. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27:949-53.
  7. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373:739-45.
  8. Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122: Suppl 3:S729-S767. [Erratum, Circulation 2011; 123 (6):e236.]
  9. Delaney B, Loy J, Kelly AM. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med 2011; 18:148-52.
  10. Braunwalds heart disease, a textbook of cardiovascular medicine, Genesis of Cardiac Arrhythmias: Electrophysiologic Considerations Michael Rubart and Douglas P. Zipes. Tenth edition, Chapter 33: 2015.Page 792.
  11. Aldhoon B, Wichterle D, Peichl P, et al.: Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace: 15:24, 2013.
  12. Tadros R, Ton A-T, Fiset C, Nattel S, Sex differences in cardiac electrophysiology and clinical arrhythmias: Epidemiology, therapeutics, and mechanisms, Canadian Journal of Cardiology (2014).
  13. Arya A, Bode K, Piorkowski C, et al. Catheter ablation of the electrical storm due to monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy: acute results and its effect on long-term survival. Pacing Clin Electrophysiol 2010; 33 (12):1504-9.
  14. Bastani H, Drca N, Insulander P, et al. Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison. Europace 2013; 15 (3):420-8.
  15. Khalil, Kanjwal, MD, Clinical Cardiac Electrophysiology Fellow, Johns Hopkins Medical Institute, Baltimore, MD, establishing the mechanism of supra ventricular tachycardia in the electrophysiology laboratory. The Journal of Innovations in Cardiac Rhythm Management, 4 (2013), 1217–1230.
  16. Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Elect. Eur Heart J 2018;39:1442–5
  17. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 2019:ehz467.
  18. Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Hear Rhythm 2015;12:1667–76
  19. Appelboam A, Reuben A, Mann C, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet 2015;386:1747–53
  20. urley AJ, Murray S, Thambyrajah J. Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used drug with potentially life-threatening adverse effects. Emerg Med J 2008;25:46–8.
  21. Stambler BS, Dorian P, Sager PT, et al. Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm. J Am Coll Cardiol 2018;72:489–97